Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches Outcomes From the Tryton Confirmatory Study

Overview of attention for article published in JACC: Cardiovascular Interventions, July 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 4,030)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 47 news stories from 46 outlets.

savesaved The Absorb bioresorbable vascular scaffold was green-lighted by the FDA for the treatment of coronary artery disease.

Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, has announced that…

Study met primary endpoint, results confirm safety profile for treatment of coronary bifurcation lesions involving large side…

/ no comments Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, today…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 43 additional news stories.